UPDATE 1-FDA staff forces advisory panel vote on Sarepta muscle drug

April 22 (Reuters) - Sarepta Therapeutics Inc'smuscle wasting drug got a new lease of life on Friday after
staff at the U.S. Food and Drug Administration made it necessary
that an independent panel...